Filing Flows › Inspire Medical Systems (INSP) › Q3 2026 › vs Q2 2026
Inspire Medical Systems (INSP) Q3 2026 vs Q2 2026 (quarter over quarter)
Inspire Medical Systems's revenue rose $6.1M (+3%) from $201M in Q2 2026 to $207M in Q3 2026.
Inspire Medical Systems, Q3 2026: revenue $207M (-8% year over year), operating margin -13.9%, net loss $24.4M, operating cash flow $46.4M. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Free cash flow margin | 18.8% | 7.0% | +11.8 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $207M | $201M | $6.1M | +3% |
| Other income, net | $3.7M | $3.6M | $77K | +2% |
| Income tax benefit | $616K | −$2.8M | $3.4M | — |
| Net loss | $24.4M | −$314K | $24.7M | — |
| Costs & expenses | $235M | $204M | $31.2M | +15% |
| Operating costs | $235M | $201M | $34.3M | +17% |
| Cost of revenue | $28.8M | $29.1M | −$285K | -1% |
| Research & development | $22.2M | $24.7M | −$2.5M | -10% |
| SG&A | $184M | $147M | $37.1M | +25% |
| Operating cash sources | $70.8M | $22.9M | $47.9M | +209% |
| Depreciation & amortization | $5.1M | $4.6M | $543K | +12% |
| Share-based compensation | $26.9M | $31.2M | −$4.3M | -14% |
| Working capital & other | $38.8M | −$12.9M | $51.7M | — |
| Net loss absorbed | $24.4M | −$314K | $24.7M | — |
| Operating cash flow | $46.4M | $23.2M | $23.2M | +100% |
| Free cash flow (OCF − capex) | $38.9M | $14.1M | $24.8M | +176% |
| Capital expenditures | $7.5M | $9.2M | −$1.6M | -18% |
Questions
How much did Inspire Medical Systems's revenue grow quarter over quarter in Q3 2026?
Inspire Medical Systems's revenue rose $6.1M (+3%) from $201M in Q2 2026 to $207M in Q3 2026.